SAVA secures $8m in seed funding from Balderton Capital and Exor Ventures to advance health monitoring microsensors
The London startup will use the capital to expand its team, develop next-generation products, and demonstrate clinical performance.
≈ £6.3M at $1 = £0.7905 on 21 Jun 2024
London-based health technology startup developing real-time and pain-free microsensors for continuous health monitoring.
London health technology startup SAVA has secured $8m in seed funding to advance its real-time health monitoring microsensors. The investment round was led jointly by Balderton Capital and Exor Ventures. The company will direct the capital toward expanding its team, designing its next-generation product line with high-throughput manufacturing capability, and demonstrating platform clinical performance.
Founded by bioengineers Renato Circi and Rafael Michali, SAVA has created a smart wearable patch that detects molecules in interstitial fluid just beneath the skin. The company recently received approval from the Medicines and Healthcare Products Regulatory Agency to conduct clinical trials for its glucose monitoring device aimed at diabetes patients. This latest investment brings the startup's total capital raised to $13m.
From the founder
"At SAVA we are tackling preventable illness by building a new operating system for health monitoring. Our microsensor will revolutionise healthcare by making world-leading monitoring technology available to all. With this capital, we can accelerate our goal of creating a new paradigm for healthcare – preventative, personalised and painless."
Renato Circi
at SAVA
Investor perspective
"This could be the defining product in personal health monitoring in the coming decade, and an essential tool for patients and clinicians in diagnosing and treating many chronic diseases as well. Renato and Rafael have a compelling user-centric vision to revolutionise chronic disease management and preventative care, and the credibility and knowledge to execute in this vital area."
James Wise
Partner, Balderton
Use of funds
- 01Grow the team
- 02Continue product development
- 03Fund research and development
